drugset
drugset / Trial / NCT02566252

Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)

NCT02566252 ↗

Phase 1 Completed 16 enrolled Pulmotect, Inc. WCCT Global · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This study evaluates the effect of pre-treatment with either cromolyn sodium or albuterol sulfate on the safety and tolerability or PUL-042 Inhalation Solution in healthy subjects.

Timeline

Start
2015-07
Primary completion
2016-01
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cromolyn Small molecule — —
Subject PUL-042 Oligonucleotide (other) — Inhaled
Subject Salbutamol Unknown — —

Indications

No indication recorded.